Clinical trialCLINICALTRIALSMar 26
Researchers at the National Institutes of Health are looking for up to 4,000 patients with rare metabolic disorders to study and treat. These are conditions where the body cannot properly break down certain substances because of missing or faulty proteins. Patients will receive exams and treatment, mostly as outpatients, though some may need to stay at the NIH Clinical Center for special tests.
WHY IT MATTERSThis trial offers patients with arterial calcification due to CD73 deficiency direct access to specialized NIH researchers and potential treatment options that may not be available elsewhere.
Clinical trialCLINICALTRIALSMar 26
Researchers at the National Heart, Lung, and Blood Institute are looking for 5,000 people who have or might have diseases that affect their heart, blood vessels, or metabolism. Participants will have blood tests and heart function tests tailored to their specific condition. Both people with these conditions and healthy people can join to help scientists understand why some people develop heart disease.
WHY IT MATTERSThis large-scale study is actively recruiting and may help identify new risk factors for heart disease in people with rare metabolic, inflammatory, and genetic conditions like Li-Fraumeni Syndrome and cardiomyopathy.